INCIDENCE RATES OF GASTROINTESTINAL PERFORATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE: REAL-WORLD EVIDENCE FROM A LARGE US NATIONWIDE CLAIMS DATABASE

被引：0
|
作者：
Ye, Yizhou
Yue, Xiaomeng
Wegrzyn, Lani R.
Lacerda, Ana P.
Colombel, Jean Frederic
Lewis, James D.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1769
引用
下载
收藏
页码：S673 / S674
页数：2
相关论文
共 50 条
  • [31] Real-World Durability of Long-Term Relapse Rates Among Patients Multiple Sclerosis Receiving Fingolimod Therapy: A Retrospective US Claims Database Analysis
    Fox, Edward
    Johnson, Kristen
    Lin, Feng
    Signorovitch, James
    Li, Nanxin
    Peeples, Miranda
    Ristovska, Ljubica
    Souroutzidis, Ariadne
    Hong, Walter
    Herrera, Vivian
    NEUROLOGY, 2016, 86
  • [32] Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY
    Cleveland, Noa Krugliak
    Ghosh, Sabyasachi
    Chastek, Benjamin
    Bancroft, Tim
    Candela, Ninfa
    Fan, Tao
    Umashankar, Kandavadivu
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2023,
  • [33] Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database
    Brailean, Anamaria
    Kwiatek, Justin
    Kielar, Danuta
    Katial, Rohit
    Wang, Xia
    Xu, Xiao
    Kim, Yong Jin
    Stokes, Michael
    Stirnadel-Farrant, Heide A.
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2023, 15 (05) : 580 - 602
  • [34] COST OF BIOMARKER TESTING AMONG PATIENTS WITH METASTATIC LUNG OR THYROID CANCER IN THE US: A REAL-WORLD COMMERCIAL CLAIMS DATABASE STUDY
    Hess, L. M.
    Michael, D.
    Krein, P. M.
    Marquart, T.
    Sireci, A. N.
    VALUE IN HEALTH, 2022, 25 (07) : S425 - S425
  • [35] Real-world use of faecal calprotectin testing in patients with inflammatory bowel disease
    Rubin, D. T.
    Yang, M.
    Wu, E. Q.
    Skup, M.
    Lee, W. -J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S162 - S163
  • [36] Real-world biologic treatment and associated cost in patients with inflammatory bowel disease
    Brandes, Alina
    Groth, Antje
    Gottschalk, Fraence
    Wilke, Thomas
    Ratsch, Boris A.
    Orzechowski, Hans-Dieter
    Fuchs, Andreas
    Deiters, Barthold
    Bokemeyer, Bernd
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (07): : 843 - 851
  • [37] Real-world prescription pattern among patients with inflammatory bowel disease in Taiwan: A multi-institutional electronic medical records database analysis
    Kou, Chon Hou
    Chang, Kaicheng
    Chen, Hui-Yu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 354 - 355
  • [38] COST AND RESOURCE USE RELATED TO NEWLY DIAGNOSED MULTIPLE SCLEROSIS: REAL-WORLD DATA FROM A LARGE US CLAIMS DATABASE
    Singer, M. E.
    Asche, C., V
    Chung, H.
    Jhaveri, M.
    Miller, A.
    VALUE IN HEALTH, 2009, 12 (07) : A367 - A367
  • [39] DEMENTIA-RELATED PSYCHOSIS: REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE UTILIZATION FROM A LARGE US ADMINISTRATIVE CLAIMS DATABASE
    Shim, A.
    Skoog, B.
    Abler, V
    Rashid, N.
    Halpern, R.
    Koep, E.
    Frazer, M.
    VALUE IN HEALTH, 2019, 22 : S191 - S191
  • [40] ADHERENCE TO DRUG-RELATED MONITORING GUIDELINES FOR MULTIPLE SCLEROSIS THERAPIES: REAL-WORLD EVIDENCE FROM A US CLAIMS DATABASE
    Lage, M. J.
    Wu, Y.
    Kolodny, S.
    VALUE IN HEALTH, 2016, 19 (07) : A435 - A435
12345